CAS 209783-80-2 appears in our catalog under these names: (Pyridin-3-yl)methyl 4-(2-aminophenylcarbamoyl)benzylcarbamate, 98%, Pyridin-3-ylmethyl 4-((2-aminophenyl)carbamoyl)benzylcarbamate, 98%, Entinostat(MS-27-275), Entinostat (MS-27-275), Entinostat (MS–275,SNDX–275). Offered by: Chemat, BLDpharm, TRC, GLPBio, TargetMol. Available pack sizes: 1mg, 100mg, 250mg, 1g, 5g, 50mg, 10mg, 5mg.
Entinostat is a member of the class of benzamides resulting from the formal condensation of the carboxy group of the pyridin-3-ylmethyl carbamate derivative of p-(aminomethyl)benzoic acid with one of the amino groups of benzene-1,2-diamine. It is an inhibitor of histone deacetylase isoform 1 (HDAC1) and isoform 3 (HDAC3). It has a role as an antineoplastic agent, an EC 3.5.1.98 (histone deacetylase) inhibitor and an apoptosis inducer. It is a member of benzamides, a carbamate ester, a member of pyridines, a substituted aniline and a primary amino compound. It is functionally related to a 1,2-phenylenediamine.
Source: ChEBI
| Molecular formula | C21H20N4O3 |
|---|---|
| Molecular weight | 376.4 g/mol |
| IUPAC name | pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate |
| InChIKey | INVTYAOGFAGBOE-UHFFFAOYSA-N |
| SMILES | C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3 |
Computed by PubChem (NCBI)